197 related articles for article (PubMed ID: 22984494)
1. Identification of drug resistant mutations in HIV-1 CRF07_BC variants selected by nevirapine in vitro.
Wu H; Zhang HJ; Zhang XM; Xu HF; Wang M; Huang JD; Zheng BJ
PLoS One; 2012; 7(9):e44333. PubMed ID: 22984494
[TBL] [Abstract][Full Text] [Related]
2. In vitro selection of HIV-1 CRF08_BC variants resistant to reverse transcriptase inhibitors.
Wu H; Zhang XM; Zhang HJ; Zhang Q; Chen Z; Huang JD; Lee SS; Zheng BJ
AIDS Res Hum Retroviruses; 2015 Feb; 31(2):260-70. PubMed ID: 25482475
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and patterns of drug-resistance mutations among HIV-1 patients infected with CRF07_BC strains in Sichuan province, China.
Su L; Zhou X; Yuan D; Yang H; Wei D; Qin G; Liang S
Virol Sin; 2014 Aug; 29(4):237-41. PubMed ID: 25160759
[TBL] [Abstract][Full Text] [Related]
4. Genetic divergence of human immunodeficiency virus type 1 Ethiopian clade C reverse transcriptase (RT) and rapid development of resistance against nonnucleoside inhibitors of RT.
Loemba H; Brenner B; Parniak MA; Ma'ayan S; Spira B; Moisi D; Oliveira M; Detorio M; Wainberg MA
Antimicrob Agents Chemother; 2002 Jul; 46(7):2087-94. PubMed ID: 12069959
[TBL] [Abstract][Full Text] [Related]
5. Novel patterns of nevirapine resistance-associated mutations of human immunodeficiency virus type 1 in treatment-naïve patients.
Hachiya A; Gatanaga H; Kodama E; Ikeuchi M; Matsuoka M; Harada S; Mitsuya H; Kimura S; Oka S
Virology; 2004 Oct; 327(2):215-24. PubMed ID: 15351209
[TBL] [Abstract][Full Text] [Related]
6. A radiolabeled oligonucleotide ligation assay demonstrates the high frequency of nevirapine resistance mutations in HIV type 1 quasispecies of NVP-treated and untreated mother-infant pairs from Uganda.
Troyer RM; Lalonde MS; Fraundorf E; Demers KR; Kyeyune F; Mugyenyi P; Syed A; Whalen CC; Bajunirwe F; Arts EJ
AIDS Res Hum Retroviruses; 2008 Feb; 24(2):235-50. PubMed ID: 18284323
[TBL] [Abstract][Full Text] [Related]
7. Impact of nevirapine (NVP) plasma concentration on selection of resistant virus in mothers who received single-dose NVP to prevent perinatal human immunodeficiency virus type 1 transmission and persistence of resistant virus in their infected children.
Chaix ML; Ekouevi DK; Peytavin G; Rouet F; Tonwe-Gold B; Viho I; Bequet L; Amani-Bosse C; Menan H; Leroy V; Rouzioux C; Dabis F
Antimicrob Agents Chemother; 2007 Mar; 51(3):896-901. PubMed ID: 17178792
[TBL] [Abstract][Full Text] [Related]
8. Clonal amplification and maternal-infant transmission of nevirapine-resistant HIV-1 variants in breast milk following single-dose nevirapine prophylaxis.
Permar SR; Salazar MG; Gao F; Cai F; Learn GH; Kalilani L; Hahn BH; Shaw GM; Salazar-Gonzalez JF
Retrovirology; 2013 Aug; 10():88. PubMed ID: 23941304
[TBL] [Abstract][Full Text] [Related]
9. Nevirapine plasma concentration is associated with virologic failure and the emergence of drug-resistant mutations among HIV patients in Kenya: A cross sectional study.
Omondi EO; Muigai A; Ngayo MO; Mungiria J; Lihana R
Medicine (Baltimore); 2022 Dec; 101(50):e32346. PubMed ID: 36550885
[TBL] [Abstract][Full Text] [Related]
10. Genetic linkage of nevirapine resistance mutations in HIV type 1 seven days after single-dose nevirapine.
Jones D; Parkin N; Hudelson SE; Guay LA; Musoke P; Mmiro F; Jackson JB; Eshleman SH
AIDS Res Hum Retroviruses; 2005 Apr; 21(4):319-24. PubMed ID: 15943576
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and transmission of pretreatment drug resistance in people living with HIV-1 in Shanghai China, 2017-2021.
Zhang M; Ma Y; Wang Z; Wang G; Wang Q; Li X; Lin F; Zhang C
Virulence; 2024 Dec; 15(1):2373105. PubMed ID: 38934465
[TBL] [Abstract][Full Text] [Related]
12. Sensitive oligonucleotide ligation assay for low-level detection of nevirapine resistance mutations in human immunodeficiency virus type 1 quasispecies.
Lalonde MS; Troyer RM; Syed AR; Bulime S; Demers K; Bajunirwe F; Arts EJ
J Clin Microbiol; 2007 Aug; 45(8):2604-15. PubMed ID: 17567789
[TBL] [Abstract][Full Text] [Related]
13. Role of low-frequency HIV-1 variants in failure of nevirapine-containing antiviral therapy in women previously exposed to single-dose nevirapine.
Boltz VF; Zheng Y; Lockman S; Hong F; Halvas EK; McIntyre J; Currier JS; Chibowa MC; Kanyama C; Nair A; Owino-Ong'or W; Hughes M; Coffin JM; Mellors JW
Proc Natl Acad Sci U S A; 2011 May; 108(22):9202-7. PubMed ID: 21576473
[TBL] [Abstract][Full Text] [Related]
14. Emergence of drug-resistant HIV-1 after intrapartum administration of single-dose nevirapine is substantially underestimated.
Johnson JA; Li JF; Morris L; Martinson N; Gray G; McIntyre J; Heneine W
J Infect Dis; 2005 Jul; 192(1):16-23. PubMed ID: 15942889
[TBL] [Abstract][Full Text] [Related]
15. Minor resistant variants in nevirapine-exposed infants may predict virologic failure on nevirapine-containing ART.
MacLeod IJ; Rowley CF; Thior I; Wester C; Makhema J; Essex M; Lockman S
J Clin Virol; 2010 Jul; 48(3):162-7. PubMed ID: 20427228
[TBL] [Abstract][Full Text] [Related]
16. The genotype distribution, infection stage and drug resistance mutation profile of human immunodeficiency virus-1 among the infected blood donors from five Chinese blood centers, 2014-2017.
Liang S; Liu Z; Wang S; Liu J; Shi L; Mao W; Liu C; Wan J; Zhu L; Huang M; Liu Y; Wang J; Ness P; Shan H; Zeng P; He M
PLoS One; 2020; 15(12):e0243650. PubMed ID: 33347449
[TBL] [Abstract][Full Text] [Related]
17. Transmitted antiretroviral drug resistance and thumb subdomain polymorphisms among newly HIV type 1 diagnosed patients infected with CRF01_AE and CRF07_BC virus in Guangdong Province, China.
Yang C; Liu S; Zhang T; Hou Y; Liu X; Gao Y; Yang G; Wang Z; Chen H; Li M; Zhu Z
AIDS Res Hum Retroviruses; 2012 Dec; 28(12):1723-8. PubMed ID: 22587343
[TBL] [Abstract][Full Text] [Related]
18. Association between detection of HIV-1 DNA resistance mutations by a sensitive assay at initiation of antiretroviral therapy and virologic failure.
Jourdain G; Wagner TA; Ngo-Giang-Huong N; Sirirungsi W; Klinbuayaem V; Fregonese F; Nantasen I; Techapornroong M; Halue G; Nilmanat A; Wittayapraparat P; Chalermpolprapa V; Pathipvanich P; Yuthavisuthi P; Frenkel LM; Lallemant M;
Clin Infect Dis; 2010 May; 50(10):1397-404. PubMed ID: 20377404
[TBL] [Abstract][Full Text] [Related]
19. Frequent nevirapine resistance in infants infected by HIV-1 via breastfeeding while on nevirapine prophylaxis.
Nelson JA; Fokar A; Hudgens MG; Compliment KJ; Hawkins JT; Tegha G; Kamwendo DD; Kayira D; Mofolo IA; Kourtis AP; Jamieson DJ; Van Der Horst CM; Fiscus SA
AIDS; 2015 Oct; 29(16):2131-8. PubMed ID: 26186128
[TBL] [Abstract][Full Text] [Related]
20. Emergence and persistence of minor drug-resistant HIV-1 variants in Ugandan women after nevirapine single-dose prophylaxis.
Hauser A; Mugenyi K; Kabasinguzi R; Kuecherer C; Harms G; Kunz A
PLoS One; 2011; 6(5):e20357. PubMed ID: 21655245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
